- Home
- SPRO vs BSBK Comparison
SPRO vs BSBK Comparison
Compare SPRO & BSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRO
- BSBK
- Stock Information
- Founded
- SPRO 2013
- BSBK 1893
- Country
- SPRO United States
- BSBK United States
- Employees
- SPRO N/A
- BSBK N/A
- Industry
- SPRO Biotechnology: Pharmaceutical Preparations
- BSBK Banks
- Sector
- SPRO Health Care
- BSBK Finance
- Exchange
- SPRO Nasdaq
- BSBK Nasdaq
- Market Cap
- SPRO 128.9M
- BSBK 109.5M
- IPO Year
- SPRO 2017
- BSBK N/A
- Fundamental
- Price
- SPRO $2.33
- BSBK $8.55
- Analyst Decision
- SPRO Buy
- BSBK
- Analyst Count
- SPRO 4
- BSBK 0
- Target Price
- SPRO $5.00
- BSBK N/A
- AVG Volume (30 Days)
- SPRO 1.2M
- BSBK 6.2K
- Earning Date
- SPRO 11-13-2025
- BSBK 10-31-2025
- Dividend Yield
- SPRO N/A
- BSBK N/A
- EPS Growth
- SPRO N/A
- BSBK N/A
- EPS
- SPRO N/A
- BSBK N/A
- Revenue
- SPRO $48,576,000.00
- BSBK $14,709,306.00
- Revenue This Year
- SPRO N/A
- BSBK N/A
- Revenue Next Year
- SPRO N/A
- BSBK N/A
- P/E Ratio
- SPRO N/A
- BSBK N/A
- Revenue Growth
- SPRO N/A
- BSBK 16.23
- 52 Week Low
- SPRO $0.51
- BSBK $6.59
- 52 Week High
- SPRO $3.22
- BSBK $9.50
- Technical
- Relative Strength Index (RSI)
- SPRO 56.08
- BSBK 34.60
- Support Level
- SPRO $2.16
- BSBK $8.52
- Resistance Level
- SPRO $2.42
- BSBK $8.94
- Average True Range (ATR)
- SPRO 0.12
- BSBK 0.21
- MACD
- SPRO -0.00
- BSBK -0.03
- Stochastic Oscillator
- SPRO 46.85
- BSBK 5.36
About SPRO Spero Therapeutics Inc.
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
About BSBK Bogota Financial Corp.
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from customers in New Jersey.